October 25, 2016 4:44 PM ET

Life Sciences Tools and Services

Company Overview of Sequenom Inc.

Company Overview

Sequenom, Inc., a life sciences company, develops and commercializes molecular diagnostics testing services for the women's health and oncology markets in the United States and internationally. The company provides molecular based laboratory developed tests (LDTs) comprising MaterniT21 PLUS LDT, a noninvasive prenatal test (NIPT) to detect fetal chromosomal abnormalities; and VisibiliT LDT, a NIPT to detect fetal chromosomal abnormalities by determining the relative amount of chromosomal material present in circulating cell-free DNA in a maternal blood sample. It also offers MaterniT21 GENOME test to detect genome-wide genomic deletions or duplications; HerediT cystic fibrosis (CF) LDT, a ca...

3595 John Hopkins Court

San Diego, CA 92121

United States

Founded in 1994

434 Employees





Key Executives for Sequenom Inc.

Chairperson, President and Secretary
Age: 56
Senior Vice President, General Counsel and Secretary
Age: 53
Senior Vice President of Corporate Governance and Regulatory Affairs
Age: 60
Chief Medical Officer and Senior Vice President
Age: 42
Executive Vice President, Treasurer and Director
Age: 55
Compensation as of Fiscal Year 2016.

Sequenom Inc. Key Developments

Sequenom Inc. Files Form 15

Sequenom Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common stock under the Securities Exchange Act of 1934, as amended. The par value of the company's common stock was $0.001 per share.

Sequenom Inc. Announces Amendments to Articles of Incorporation and Bylaws

In connection with the closing of the Merger Sequenom Inc. and Wells Fargo Bank, National Association entered into a First Supplemental Indenture, dated as of September 7, 2016 to the Indenture, dated as of September 17, 2012, between Sequenom and Wells Fargo Bank, National Association, relating to the company's 5.00% Convertible Senior Notes due 2017, and a First Supplemental Indenture, dated as of September 7, 2016 to the Indenture, dated as of June 9, 2015, between the company and the Trustee, relating to the company's 5.00% Convertible Exchange Senior Notes due 2018.

Sequenom Inc. Announces Executive Changes

Sequenom Inc. entered into an Agreement and Plan of Merger with Laboratory Corporation of America Holdings and Savoy Acquisition Corp. and direct wholly owned subsidiary of LabCorp. Pursuant to the Merger Agreement, effective as of the Effective Time, on September 7, 2016, each of Kenneth F. Buechler, Myla Lai-Goldman, Richard A. Lerner, Ronald M. Lindsay, David Pendarvis, Catherine J. Mackey, Charles P. Slacik and Dirk van den Boom resigned as a director of the Company and from any committees of the Company's Board of Directors on which they then served. In addition, pursuant to the Merger Agreement and effective as of immediately after the Effective Time, on September 7, 2016, Glenn A. Eisenberg, F. Samuel Eberts III, Sandra D. van der Vaart, William B. Haas and Benjamin R. Miller were appointed to the Board of Directors of the Company. Further, pursuant to the Merger Agreement, effective as of the Effective Time, on September 7, 2016, F. Samuel Eberts III became Chairperson, President and Secretary of the Company, replacing Dirk van den Boom as Chief Executive Officer, President and principal executive officer of the Company, and Glenn A. Eisenberg became Executive Vice President and Treasurer of the Company, replacing Carolyn D. Beaver as Senior Vice President and Chief Financial Officer and principal financial and accounting officer of the Company. Each of Glenn A. Eisenberg and F. Samuel Eberts III is an officer of LabCorp.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

July 27, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sequenom Inc., please visit www.sequenom.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.